尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Heron Elaine J, 董事. Officer active across 3 companies, notably Biomarin Pharmaceutical INC. Cumulatively, 14 disclosures have been published. Split: 2 buys · 0 sell. Total volume traded: €262k. Activity tracked since 25 May 2021. The latest transaction was filed on 16 July 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 条申报中的 14 条
Administrateur at Biomarin Pharmaceutical INC, Vaxart, Inc. and PALVELLA THERAPEUTICS, INC., HERON ELAINE J has 14 filings in total. Across the 14 sampled recent filings, the date range runs from 2021-05-27 to 2026-07-17, with buy volume of EUR 262027 and no sell volume, and the most frequent transaction nature is Attribution.